Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $270K | ﹤0.01% |
11,700
-337,000
| -97% | -$8.09M |
|
3077
ASML
ASML
$710B
| $270K | ﹤0.01% |
+386
| New | +$277K |
|
3078
Richmond Mutual Bancorp
RMBI
$257M
| $267K | ﹤0.01% |
18,842
+300
| +2% | +$4.09K |
|
|
CDTG
3079
CDT Environmental Technology Investment Holdings
CDTG
$3.69M
| $266K | ﹤0.01% |
+2,392
| New | +$198K |
|
3080
Comscore
SCOR
$108M
| $265K | ﹤0.01% |
45,436
+4,115
| +10% | +$27.5K |
|
3081
Versus Systems
VS
$8.2M
| $265K | ﹤0.01% |
+120,600
| New | +$223K |
|
3082
Fidelity MSCI Utilities Index ETF
FUTY
$2.31B
| $263K | ﹤0.01% |
+5,400
| New | +$275K |
|
3083
Covenant Logistics
CVLG
$865M
| $262K | ﹤0.01% |
9,600
-54,314
| -85% | -$1.49M |
|
3084
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $262K | ﹤0.01% |
10,000
-76,000
| -88% | -$2.04M |
|
3085
NCS Multistage Holdings
NCSM
$134M
| $261K | ﹤0.01% |
+10,044
| New | +$222K |
|
3086
Urban One Class D
UONEK
$24.1M
| $258K | ﹤0.01% |
25,951
-2,180
| -8% | -$22.7K |
|
|
PVLA
3087
Palvella Therapeutics
PVLA
$2.23B
| $256K | ﹤0.01% |
21,371
-10,800
| -34% | -$170K |
|
3088
Neuronetics
STIM
$223M
| $255K | ﹤0.01% |
158,600
-423,200
| -73% | -$440K |
|
3089
Greenwich LifeSciences
GLSI
$248M
| $255K | ﹤0.01% |
22,700
-9,800
| -30% | -$131K |
|
3090
Cocrystal Pharma
COCP
$15.4M
| $254K | ﹤0.01% |
125,828
-4,200
| -3% | -$8.4K |
|
3091
Genius Sports
GENI
$2.12B
| $253K | ﹤0.01% |
+29,200
| New | +$244K |
|
3092
Kopin
KOPN
$898M
| $252K | ﹤0.01% |
185,623
-6,293
| -3% | -$6.04K |
|
3093
Transcontinental Realty Investors
TCI
$318M
| $250K | ﹤0.01% |
8,400
+100
| +1% | +$2.83K |
|
3094
iShares US Utilities ETF
IDU
$1.38B
| $250K | ﹤0.01% |
+2,600
| New | +$262K |
|
|
VNET
3095
VNET Group
VNET
$2.11B
| $250K | ﹤0.01% |
+52,700
| New | +$200K |
|
|
VLRS
3096
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $249K | ﹤0.01% |
33,500
-700
| -2% | -$5.24K |
|
3097
Willamette Valley Vineyards
WVVI
$11.5M
| $249K | ﹤0.01% |
74,352
-3,300
| -4% | -$11.2K |
|
3098
Retractable Technologies
RVP
$20.2M
| $249K | ﹤0.01% |
361,253
+31,140
| +9% | +$21.4K |
|
3099
First Financial Bancorp
FFBC
$3.6B
| $248K | ﹤0.01% |
+9,237
| New | +$252K |
|
|
FWDI
3100
Forward Industries Inc
FWDI
$305M
| $248K | ﹤0.01% |
50,093
-1,900
| -4% | -$7.64K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.